Janet A. Englund, MD: Professor of Pediatric Infectious Diseases. My research interests include the study of vaccine-preventable diseases and viral respiratory diseases in young children and immunocompromised hosts, including transplant recipients, as well as the evaluation of antiviral therapy for the prevention and treatment of viral diseases.
As a leader in the field of infectious diseases (ID), respiratory viruses, and infections in children, I have particular interests in assessing the epidemiology of the study of viral infections and assessing vaccine effectiveness. As a member of the CDC-sponsored New Vaccine Surveillance Network, I work with Dr. Klein to direct protocol development and patient enrollment to assess viral epidemiology and vaccine effectiveness for acute respiratory and gastrointestinal disease. Our Pediatric ID Research group is actively involved in the follow-up of pregnant women and a longitudinal study of children infected with SARS-CoV-2. Over the past 30 years, I have had extensive experience in initiating, managing, and analyzing clinical trials, vaccine studies, and national and international research protocols, in addition to a track record for successful collaborative research. I have played leadership roles in multicenter, federally-sponsored networks and research trial units, including the NIH-sponsored AIDS Clinical Trials Unit, the Vaccine Treatment and Evaluation Unit, and New Vaccine Surveillance Network (NVSN). My interest in protecting patients from viral diseases has contributed to national and international policies regarding pediatric immunization with rotavirus and papillomavirus vaccines, and maternal immunization with respiratory syncytial virus, influenza and pertussis vaccines. I am enthusiastic to work to further our understanding of important respiratory and enteric viral infections, and to contribute to controlling the spread of SARS-CoV-2.
